Department of Paediatrics, University of Parma, Parma, Italy.
Clin Endocrinol (Oxf). 2008 Jan;68(1):22-8. doi: 10.1111/j.1365-2265.2007.02992.x. Epub 2007 Aug 6.
To evaluate changes and relationships of IGFs and IGFBPs, serum interleukin 6 (IL-6) and tumour necrosis factor (TNF)-alpha, and auxological parameters at diagnosis of coeliac disease (CD) and at 6 months and 12 months after starting a gluten-free diet (GFD), compared with a control population.
Twenty patients were enrolled at diagnosis (9 male, 11 female; age 9.6 +/- 0.8 years). A healthy population of 18 subjects (5 male, 13 female; age 11.3 +/- 0.6 years) comparable for age, sex and pubertal status served as controls at baseline.
Blood samples were taken at diagnosis, and at 6 months and 12 months after starting the GFD. Serum IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3, IL-6 and TNF-alpha were measured using commercial kits. Height (Ht) standard deviation score (SDS), body mass index (BMI) SDS and Ht velocity SDS were evaluated at diagnosis and at 6 months and 12 months after starting GFD.
In CD patients, both Ht SDS and BMI SDS increased during the first year of treatment, and Ht velocity SDS increased during the second 6 months of follow-up (P < 0.05). At diagnosis, IGF-I, IGF-II and IGFBP-3 were lower compared with controls, IGFBP-1 was similar, IGFBP-2, IL-6 and TNF-alpha were higher (P < 0.05). When on GFD, all peptides normalized and IGFBP-1 decreased. The IGF-I/IGFBP-2 and IGF-I/IGFBP-3 molar ratios were significantly reduced at diagnosis compared with those of controls, but were increased for both groups when on GFD. Although there was no apparent abnormality at diagnosis, the IGF-II/IGFBP-2 molar ratio increased significantly on GFD. Ht velocity SDS was positively correlated with IGFBP-3 (P < 0.05) and with the IGF-I/IGFBP-2 molar ratio (P < 0.05). Serum IL-6 was negatively correlated with IGF-I and positively with IGFBP-1 (P < 0.05).
The data obtained from this study confirm changes in the IGF and cytokine systems at diagnosis of CD which tend to normalize on the gluten-free diet. The two systems show relationships with each other and with linear growth.
评估乳糜泻(CD)患者在诊断时以及开始无麸质饮食(GFD)后 6 个月和 12 个月时 IGFs 和 IGFBPs、血清白细胞介素 6(IL-6)和肿瘤坏死因子(TNF)-α的变化及其与人体测量学参数的关系,并与对照组进行比较。
20 名患者在诊断时(9 名男性,11 名女性;年龄 9.6±0.8 岁)入组。18 名年龄、性别和青春期状态相匹配的健康受试者(5 名男性,13 名女性;年龄 11.3±0.6 岁)作为对照组。
在诊断时以及开始 GFD 后 6 个月和 12 个月时采集血样。使用商业试剂盒测量血清 IGF-I、IGF-II、IGFBP-1、IGFBP-2、IGFBP-3、IL-6 和 TNF-α。在诊断时和开始 GFD 后 6 个月和 12 个月评估身高(Ht)标准偏差评分(SDS)、体重指数(BMI)SDS 和 Ht 速度 SDS。
在 CD 患者中,治疗的第一年 Ht SDS 和 BMI SDS 增加,随访的第二个 6 个月 Ht 速度 SDS 增加(P<0.05)。在诊断时,IGF-I、IGF-II 和 IGFBP-3 低于对照组,IGFBP-1 相似,IGFBP-2、IL-6 和 TNF-α 更高(P<0.05)。开始 GFD 后,所有肽均正常化,IGFBP-1 下降。IGF-I/IGFBP-2 和 IGF-I/IGFBP-3 摩尔比在诊断时明显低于对照组,但在 GFD 时均增加。尽管在诊断时没有明显异常,但 IGF-II/IGFBP-2 摩尔比在 GFD 时显著增加。Ht 速度 SDS 与 IGFBP-3 呈正相关(P<0.05),与 IGF-I/IGFBP-2 摩尔比呈正相关(P<0.05)。血清 IL-6 与 IGF-I 呈负相关,与 IGFBP-1 呈正相关(P<0.05)。
本研究获得的数据证实,CD 患者在诊断时 IGF 和细胞因子系统发生变化,在无麸质饮食时趋于正常化。两个系统彼此之间以及与线性生长之间存在关系。